Evidence map›Paper›PMID 42238754›Full record

ArticleBasic and clinical neuroscience2025

Predicting the Conversion From Mild Cognitive Impairment to Alzheimer's Disease Using Graph Frequency Bands and Functional Connectivity-based Features.

Jafar Zamani, Alireza Talesh Jafadideh

Abstract read
In one paragraph

Article in Basic and clinical neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Jafar ZamaniDepartment of Psychiatry and Behavioral Sciences, Stanford University, California, United States.ORCID https://orcid.org/0000-0002-1621-3751
Alireza Talesh JafadidehSchool of Engineering Science, College of Engineering, University of Tehran, Tehran, Iran.ORCID https://orcid.org/0000-0003-0758-5622

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Accurate prediction of the progression from mild cognitive impairment (MCI) to Alzheimer's disease (AD) is crucial for disease management. Machine learning techniques have demonstrated success in classifying AD and MCI cases, particularly using resting-state functional magnetic resonance imaging (rs-fMRI) data. Methods: This study utilized rs-fMRI data from the ADNI, involving 142 patients with stable MCI (sMCI) and 136 with progressive MCI (pMCI). Graph signal processing was applied to filter rs-fMRI data into low-, middle-, and high-frequency bands. Connectivity-based features were derived from both filtered and unfiltered data, resulting in a comprehensive set of 100 features, including global graph metrics, minimum spanning tree (MST) metrics, triadic interaction metrics, hub tendency metrics: and number of links. Feature selection was enhanced using particle swarm optimization (PSO) and simulated annealing (SA). A support vector machine (SVM) with a radial basis function (RBF) kernel and a 10-fold cross-validation setup were employed for classification. Results: The proposed approach achieved high accuracy with a reduced number of features selected via PSO, specifically five features. With these features: the SVM achieved 77% accuracy, 70% specificity, and 83% sensitivity. The identified features were as follows, (mean of clustering coefficient, mean of strength)/radius/(mean eccentricity, and modularity) from low/middle/high frequency bands of the graph. Conclusion: This study highlights the efficacy of the proposed framework in identifying individuals at risk of developing AD using a parsimonious feature set. This approach holds promise for advancing the precision of MCI-to-AD progression prediction, aiding early diagnosis and intervention strategies.

Indexed as

Alzheimer’s disease (AD)ClassificationConnectivity-based featuresGraph signal processingMild cognitive impairment (MCI)

Identifiers

PMID42238754
PMCPMC13228114

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.